MedTrace Logo

BioMonitor 2 In-Office Setting Insertion Safety and Feasibility Evaluation With Device Functionality Assessment

NCT02756338 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2018-10-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and feasibility of performing the BioMonitor 2 insertion procedure in an office setting.

Conditions

  • Insertable Cardiac Monitor

Interventions

DEVICE

BioMonitor 2 Insertable Cardiac Monitor

Sponsors & Collaborators

  • Biotronik, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02756338 on ClinicalTrials.gov